Ji Ha Choi

1.2k total citations
36 papers, 917 citations indexed

About

Ji Ha Choi is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ji Ha Choi has authored 36 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Surgery. Recurrent topics in Ji Ha Choi's work include Drug Transport and Resistance Mechanisms (12 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Metabolism and Genetic Disorders (3 papers). Ji Ha Choi is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers) and Metabolism and Genetic Disorders (3 papers). Ji Ha Choi collaborates with scholars based in South Korea, United States and Canada. Ji Ha Choi's co-authors include Eun‐Mi Park, Kathleen M. Giacomini, Walter L. Miller, Vishal Agrawal, Min Goo Lee, Ji Hyun Lee, Jong Eun Lee, Minsuk Kim, Jihee Lee Kang and Youn‐Hee Choi and has published in prestigious journals such as Biomaterials, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ji Ha Choi

34 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Ha Choi South Korea 17 348 239 147 139 106 36 917
Dilek Iusuf Netherlands 14 205 0.6× 343 1.4× 61 0.4× 99 0.7× 66 0.6× 16 668
Sri Nagarjun Batchu Canada 20 444 1.3× 91 0.4× 161 1.1× 83 0.6× 288 2.7× 36 1.1k
Jun Hao China 23 629 1.8× 107 0.4× 146 1.0× 60 0.4× 91 0.9× 57 1.3k
Chengguo Wei United States 18 453 1.3× 72 0.3× 110 0.7× 70 0.5× 91 0.9× 28 1.1k
Laura Conde de la Rosa United States 18 515 1.5× 244 1.0× 201 1.4× 184 1.3× 89 0.8× 23 1.3k
Bernard Bouscarel United States 23 563 1.6× 545 2.3× 372 2.5× 116 0.8× 142 1.3× 54 1.4k
Ying Su China 22 700 2.0× 138 0.6× 79 0.5× 32 0.2× 83 0.8× 52 1.4k
Grant Bledsoe United States 22 484 1.4× 91 0.4× 84 0.6× 60 0.4× 72 0.7× 26 1.2k
Carole S. Frye United States 10 572 1.6× 119 0.5× 105 0.7× 80 0.6× 71 0.7× 11 1.3k
Qingjuan Liu China 23 523 1.5× 94 0.4× 105 0.7× 34 0.2× 74 0.7× 52 1.1k

Countries citing papers authored by Ji Ha Choi

Since Specialization
Citations

This map shows the geographic impact of Ji Ha Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Ha Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Ha Choi more than expected).

Fields of papers citing papers by Ji Ha Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Ha Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Ha Choi. The network helps show where Ji Ha Choi may publish in the future.

Co-authorship network of co-authors of Ji Ha Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Ha Choi. A scholar is included among the top collaborators of Ji Ha Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Ha Choi. Ji Ha Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Ji Ha, et al.. (2026). Necrotic Cells Alter IRE1α-XBP1 Signaling and Induce Transcriptional Changes in Glioblastoma. International Journal of Molecular Sciences. 27(1). 474–474.
2.
Song, Hyo Sook, et al.. (2025). Effect of SLC5A8 Missense Variants on Its Tumor-Suppressive Function. Journal of Korean Medical Science. 40(27). e146–e146.
3.
Ha, Seung Yeon, Jinyoung Kim, & Ji Ha Choi. (2024). Transcriptional regulation of genetic variants in the SLC40A1 promoter. Korean Journal of Physiology and Pharmacology. 28(2). 113–120. 3 indexed citations
4.
Song, Hyo Sook, et al.. (2022). Functional characterization of ABCA4 genetic variants related to Stargardt disease. Scientific Reports. 12(1). 22282–22282. 7 indexed citations
5.
Kim, Woo Jin, et al.. (2018). Association between Genetic Variations of MERTK and Chronic Obstructive Pulmonary Disease in Koreans. Journal of Korean Medical Science. 33(7). e56–e56. 1 indexed citations
6.
Shin, Jin A., Dong‐Ryeol Ryu, Young‐Ho Ahn, et al.. (2018). Repression of adenosine triphosphate–binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury. Neurobiology of Aging. 66. 138–148. 6 indexed citations
7.
Lee, Ye-Ji, et al.. (2018). Apoptotic cells trigger the ABCA1/STAT6 pathway leading to PPAR-γ expression and activation in macrophages. Journal of Leukocyte Biology. 103(5). 885–895. 19 indexed citations
8.
Shim, So‐Yeon, Hyojin Park, Youn‐Hee Choi, et al.. (2017). Functional variation of SHP-2 promoter is associated with preterm birth and delayed myelination and motor development in preterm infants. Scientific Reports. 7(1). 6052–6052. 2 indexed citations
9.
Park, Hyojin, Tae Hee Kim, So Won Kim, et al.. (2016). Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3. Scientific Reports. 6(1). 26872–26872. 21 indexed citations
10.
Choi, Yun Seong, et al.. (2016). A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform. The Pharmacogenomics Journal. 17(2). 174–179. 19 indexed citations
11.
Park, Hyojin, Eun Suk Jung, Kyoung Ae Kong, et al.. (2016). Identification of OCTN2 variants and their association with phenotypes of Crohn’s disease in a Korean population. Scientific Reports. 6(1). 22887–22887. 15 indexed citations
13.
Ahn, So‐Hee, Hyun‐Ju Park, Jungsul Lee, et al.. (2014). Transcriptional regulation of adrenomedullin by oncostatin M in human astroglioma cells: Implications for tumor invasion and migration. Scientific Reports. 4(1). 6444–6444. 15 indexed citations
14.
Kim, Tae Hee, et al.. (2013). Identification and functional characterization of novel MATE1 genetic variations in Koreans. Biochemical and Biophysical Research Communications. 434(2). 334–340. 7 indexed citations
15.
Chung, Jae‐Yong, Sung Kweon Cho, Tae Hee Kim, et al.. (2013). Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics. Pharmacogenetics and Genomics. 23(7). 365–373. 19 indexed citations
16.
Park, Hyun-Jung, et al.. (2012). Upregulation of Mer Receptor Tyrosine Kinase Signaling Attenuated Lipopolysaccharide-Induced Lung Inflammation. Journal of Pharmacology and Experimental Therapeutics. 344(2). 447–458. 40 indexed citations
17.
Shin, Jin A., Ji Ha Choi, Youn‐Hee Choi, & Eun‐Mi Park. (2011). Conserved aquaporin 4 levels associated with reduction of brain edema are mediated by estrogen in the ischemic brain after experimental stroke. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(9). 1154–1163. 41 indexed citations
18.
Shin, Jin A., et al.. (2010). Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. Journal of Neuroimmunology. 227(1-2). 93–100. 80 indexed citations
19.
Chen, Ligong, Eugene Chen, Avner Schlessinger, et al.. (2010). Genetic Polymorphisms in Organic Cation Transporter 1 (OCT1) in Chinese and Japanese Populations Exhibit Altered Function. Journal of Pharmacology and Experimental Therapeutics. 335(1). 42–50. 70 indexed citations
20.
Choi, Ji Ha, Sook Wah Yee, Mee J. Kim, et al.. (2009). Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1. Pharmacogenetics and Genomics. 19(10). 770–780. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026